Search results
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies - Cell...
Nature· 3 days agoThe chemotherapy options for patients with the most aggressive types of solid cancers remain very limited because of the acquired drug resistance, making ...
Climate Change Is a Worse Health Threat Than We Think | by Manica Balasegaram - Project Syndicate
Project Syndicate· 3 days agoManica Balasegaram warns that the world is underestimating the extent to which global warming will...
Scientists track 'doubling' in origin of cancer cells
Medical Xpress· 3 days agoThe findings, published in Science, reveal what goes wrong when a group of molecules and enzymes trigger and regulate what's known as the "cell cycle," the repetitive process of making new cells ...
Alarming superbug from deadly eyedrop outbreak has spread to dogs
Ars Technica· 4 days agoThe two dogs in New Jersey were not known to have received the drops linked to the outbreak:...
Lung Cancer Research Foundation Welcomes New Scientific Advisory Board Members
WFRV 5 Green Bay· 5 days agoThe Lung Cancer Research Foundation (LCRF) has expanded its Scientific Advisory Board (SAB) by five new members. Led by Katerina Politi, PhD, Associate Professor of Pathology and Internal Medicine ...
Deeper understanding of malaria parasite sexual development unlocks opportunities to block disease...
Phys.org· 3 days agoThe study, published in Science, details the critical developmental stages of the malaria parasite,...
“Super Gonorrhea” Has Arrived
Journal of the American Medical Association· 2 days agoThe clock is ticking on effective gonorrhea treatments—some say since 2018, when researchers in the UK reported the first Neisseria gonorrhoeae strain...
Delphia starts up with $67M to make a new type of cancer drug
BioPharma Dive via Yahoo Finance· 3 days agoThe startup is developing medicines designed to overstress cellular pathways to the point tumor...
Deciphera Pharmaceuticals (NASDAQ:DCPH) Given “Neutral” Rating at Guggenheim
ETF DAILY NEWS· 3 days agoDeciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report)‘s stock had its “neutral” rating reissued by analysts at Guggenheim in a research note issued on Tuesday, Benzinga reports. Several ...
UTIs make life miserable — scientists are finding new ways to tackle them
Nature· 3 days agoResearchers are developing vaccines and fresh drug approaches to prevent and treat recurring...